first glp 1 drug GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness New GLP-1 Guidelines for Type

doi: 10.2337/db18-1123 55 MentisNVardarliIKtheLDHolstJJDeaconCFTheodorakisMet al

Liu J, Pong A, Gallo S, Darekar A, Terra SG

The GLP-1 receptor agonists studied included semaglutide (Wegovy/Ozempic, Novo Nordisk), exenatide (Bydureon, AstraZeneca), liraglutide (Saxenda, Novo Nordisk) and dulaglutide (Trulicity, Eli Lilly)

Further evidence supporting this hypothesis comes from the typical decrease in bone turnover observed after oral glucose intake, which is inhibited by infusion of octreotide, a somatostatin analog that suppresses the secretion of gastrointestinal and pancreatic peptides [43]

Tirzepatide, a GLP-1 receptor agonist, regulates appetite and glucose levels, making it an effective tool for weight management and improving insulin sensitivity

These medicines mimic the action of the naturally occurring hormone GLP-1, which is released by the intestine in response to food intake